Altshuler Shaham LTD Insmed Inc Transaction History

Altshuler Shaham LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 13, 2021	SELL	$32.28 - $44.3 $138,029 - $189,426	-4,276 Closed	0 $0
Q1 2020 May 12, 2020	SELL	$13.63 - $33.98 $7,019 - $17,499	-515 Reduced 10.75%	4,276 $69,000
Q3 2019 Nov 12, 2019	BUY	$15.49 - $25.78 $3,206 - $5,336	207 Added 4.52%	4,791 $88,000
Q2 2019 Aug 06, 2019	SELL	$23.0 - $32.19 $1.43 Million - $2.01 Million	-62,366 Reduced 93.15%	4,584 $117,000
Q1 2019 May 15, 2019	BUY	$13.91 - $31.15 $189,176 - $423,640	13,600 Added 25.49%	66,950 $1.95 Million
Q4 2018 Feb 11, 2019	SELL	$11.6 - $18.7 $1,740 - $2,805	-150 Reduced 0.28%	53,350 $700,000
Q3 2018 Nov 13, 2018	BUY	$18.95 - $28.08 $1.01 Million - $1.5 Million	53,500 New	53,500 $1.08 Million

480

182M

2.27M

3.32M

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $10.6B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

Get notified when there are updates to the investment portfolio of Altshuler Shaham LTD, based on Form 13F filings with the SEC.

Stay updated on Altshuler Shaham LTD with notifications on news.